Navigation Links
Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting

Preliminary data from an ongoing Phase 2 trial evaluating satraplatin plus Taxol(R) (paclitaxel) in the first-line treatment of patients with advanced non-small cell lung cancer were also published in the ASCO educational book (Shipley, D. et al. Phase II trial of satraplatin and paclitaxel in the first-line treatment of advanced non-small cell lung cancer). Data from 24 patients were available for analysis; a total of approximately 40 patients are expected to be enrolled in the study. This preliminary analysis showed that satraplatin plus Taxol appears to have activity in this treatment setting. In an effort to reduce myelosuppression in the study, the satraplatin dose has been lowered to 70 mg/m2 from 80 mg/m2. The study continues to enroll and follow patients.

About Satraplatin

Satraplatin, an investigational drug, is a member of the platinum family of compounds. Platinum-based drugs are a critical part of modern chemotherapy treatments and are used to treat a wide variety of cancers. All platinum drugs currently on the market require intravenous administration. Satraplatin is an oral compound that clinical trial patients are able to take at home. Satraplatin is not currently approved by the FDA in the United States, by the EMEA in the European Union or any other regulatory authority and no conclusions can or should be drawn regarding its safety and efficacy.

A Phase 3 registrational trial, called SPARC, is evaluating satraplatin plus prednisone versus placebo plus prednisone in 950 patients with hormone- refractory prostate cancer whose prior chemotherapy has failed. Data from the trial on progression-free survival and on safety have been presented at recent medical conferences.

GPC Biotech has a co-development and license agreement with Pharmion GmbH, a wholly owned subsidiary of Pharmion Corporation, under which Pharmion has been granted exclusive commercialization rights to satraplatin for Europe and certain other territories.
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
10. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
11. PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
Post Your Comments:
(Date:9/12/2014)... LAUSANNE , Switzerland , September ... Genetics, leader européen de la médecine basée sur les ... son premier contrat avec le National Health Service au ... Cela fait suite à une forte hausse de la ... cliniques émanant des laboratoires et hôpitaux en Allemagne, en ...
(Date:9/12/2014)...  WellStar Paulding Hospital is the first hospital in ... in the U.S. to offer a new, innovative procedure ... System, Paulding Hospital is on the cutting edge of ... Inspire Therapy offers relief for moderate to ... to use traditional treatments, like Continuous Positive Airway Pressure ...
(Date:9/12/2014)... , Sept. 12, 2014 ... of the "Global Medical Technologies Market 2014-2018" ... Medical technology is a collective term for software ... to ensure good health. The Global Medical Technologies ... and respiratory technology, In vitro diagnostics technology, dental ...
Breaking Medicine Technology:Sophia Genetics annonce son premier contrat avec le National Health Service britannique et un grand laboratoire turc, élargissant ainsi sa clientèle européenne 2WellStar Pioneers New Sleep Apnea Treatment 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 3
... Transgenomic, Inc. (OTC/BB: TBIO) today announced the ... Results and Business Update Conference CallWhen: , Thursday, August ... How: , Live over the Internet -- Simply log ... Investor Relations, 402-452-5400To access the call via telephone, call ...
... 11, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... pharmaceutical and biotechnology research and development outsourcing company, today ... two multi-staged projects in its biologics division, which portends ... The initial milestones were achieved for two oncology ...
Cached Medicine Technology:Transgenomic to Hold Second Quarter Financial Results Conference Call Today 2ShangPharma's Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects 2
(Date:9/14/2014)... Top10BestSEOHosting.com always offers truly reliable information for ... carefully, the site has announced that Arvixe ( ... WordPress Hosting suppliers in the current market. , ... hosting provider, and the company’s reputation for reliability ... known for its flexible hosting packages, decent uptime ...
(Date:9/14/2014)... September 14, 2014 Final Cut Pro ... the production of the Flip Flop Theme template for ... Flop is a simple-to-use and simplistic template that allows ... ease in Final Cut Pro X," said Christina Austin, ... and On-Screen controls, the user has controls of the ...
(Date:9/13/2014)... Recently, an experienced supplier of wedding ... its new collection of eggplant evening dresses . ... discounted rates, up to 58% off. According to the ... September 23. , The company’s new items are ... vintage, plus size, modest, sexy outfits and so on. ...
(Date:9/13/2014)... Ticket Down is a dependable ... beloved pop-rock group that originally formed in 1994 in Los ... of the group had been anticipating a new album since ... excited yet about the release of their new album, they ... a massive worldwide tour beginning in the United States in ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 MillionaireSinglesDating.com ... by Successful Match, the leading niche dating services ... site PositiveSingles.com, the leading sugar daddy site ... site , InterracialMatch.com. The site has recently reached ... millionaire singles and admirers. The members include CEOs, ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:Pixel Film Studios Releases Flip Flop Theme for Final Cut Pro X Users 2Health News:Cheap Eggplant Evening Dresses Now Announced By Experienced Company iFitDress.com 2Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 2Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 3Health News:MillionaireSinglesDating.com Reaches 2 Million Users Milestone 2
... Adults with type 2 diabetes who eat unhealthy, ... this can be offset by taking antioxidant vitamins with ... There is already growing evidence linking diabetes to cognitive ... are especially vulnerable to acute meal-induced memory deficits after ...
... Form 10-Q,s for First Three Quarters of Fiscal 2008 ... for Fiscal 2008 Ended March 31, 2008 Points to ... ... ST. LOUIS, June 25 KV Pharmaceutical Company,(NYSE: KVa/KVb), a ...
... in Oral Biology Award will be presented to Dr. ... Pediatric Dentistry, University of Alabama at Birmingham School of ... for Dental Research (IADR) at its 86th General Session ... Dr. Childers, research has contributed to the understanding of ...
... Canada As part of the Opening Ceremonies of ... Metro Toronto Convention Centre, the International Association for Dental ... follow: , IADR Honorary Membership ... may select an Honorary Member who has made significant ...
... N.C., June 25 New research that explores,the tactics ... management is now available in the Best Practice Database, ... Best,Practices, LLC., To review sample key findings and ... with links to each study at this address:, http://www3.best-in-class.com/dr319.htm ...
... there,s a new infant formula that blocks transmission of ... status during pregnancy will affect her baby,s future dental ... prevents early-childhood tooth decay? ,These are but a few ... be presented when the International,Association for Dental Research (IADR) ...
Cached Medicine News:Health News:Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal 2Health News:Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal 3Health News:KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission 2Health News:KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission 3Health News:KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission 4Health News:International Association for Dental Research presents awards and fellowships 2Health News:International Association for Dental Research presents awards and fellowships 3Health News:International Association for Dental Research presents awards and fellowships 4Health News:International Association for Dental Research presents awards and fellowships 5Health News:Best Practice Database Adds Research on New Product Commercialization 2Health News:International Dental Research Association meets in Toronto 2Health News:International Dental Research Association meets in Toronto 3Health News:International Dental Research Association meets in Toronto 4
PDA-version of the leading portable drug reference....
PDA formatted guide containing outlines and detailed information on the diagnosis and treatment of HIV infection and AIDS....
PDA application contains 15,000+ ICD-9-CM Diagnosis codes....
Information on diagnosis and management of 500 common or important medical and surgical disorders....
Medicine Products: